Workflow
研报掘金丨东莞证券:首予威高血净“增持”评级,核心产品市场份额占比位居行业第一

Core Viewpoint - Weigao Blood Purification focuses on the research, production, and sales of medical products for blood purification, with a significant market presence in China [1] Company Overview - The company has developed a series of hemodialysis products that meet or exceed the performance indicators of leading international competitors, establishing itself as an industry leader [1] - Weigao Blood Purification has successfully broken through the technical barriers long dominated by international manufacturers in the high-tech segment of hemodialysis devices [1] Market Position - According to Frost & Sullivan, the company holds a market share of 32.5% in the Chinese hemodialysis device market and 31.8% in the hemodialysis tubing market, both ranking first in the industry [1] - As a leading enterprise in the domestic blood purification industry, the company's core product market share is the highest in the sector [1] Investment Rating - The company has been given an "Overweight" rating in its initial coverage [1]